GlassScriptPhysician profile
Heather J Delagrange
NPI 1174029342
$4,355.56
in general payments reported to CMS, 2019-2025
36 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $198 · 2022: $1,089 · 2023: $580 · 2024: $1,067 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,068.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $613.58 | 2022-2023 | Axonics |
| Accord Healthcare, INC. | $458.88 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $432.31 | 2022-2025 | |
| Janssen Biotech, INC. | $323.03 | 2021-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $250.39 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Sumitomo Pharma America, INC. | $222.92 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $182.59 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $167.59 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $167.05 | 2022-2025 | Lynparza |
| Astellas Pharma US INC | $141.77 | 2021-2024 | Xtandi, Myrbetriq |
| Urogen Pharma, INC. | $137.62 | 2024-2025 | |
| Genzyme Corporation | $119.23 | 2022-2023 | |
| Coloplast Corp | $100.01 | 2024-2025 | |
| Pfizer INC. | $95.62 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $87.73 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $81.83 | 2023-2025 | Pylarify |
| Boston Scientific Corporation | $80.96 | 2025 | Ams 700 |
| Dentsply Ih Ab | $75.40 | 2024 | Lofric |
| Myriad Genetic Laboratories, INC. | $71.70 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $66.63 | 2025 | Provenge |
| Medtronic, INC. | $52.90 | 2021-2025 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $48.81 | 2023 | Bard Urinary Drainage Bag |
| Sun Pharmaceutical Industries INC. | $45.62 | 2023 | Yonsa |
| Endo Pharmaceuticals INC. | $41.49 | 2021 | |
| Calyxo, INC. | $40.68 | 2025 | Cvac Aspiration System |
| Myovant Sciences INC. | $34.08 | 2022 | |
| Immunitybio, INC. | $33.27 | 2024 | |
| Tolmar, INC. | $28.71 | 2023 | |
| Antares Pharma, INC. | $26.85 | 2022 | |
| Urovant Sciences INC | $22.55 | 2022 | |
| Procept Biorobotics Corporation | $21.00 | 2024 | Aquabeam System |
| Teleflex LLC | $18.01 | 2025 | Barrigel |
| Amgen INC. | $17.46 | 2021 | |
| Cycle Pharmaceuticals INC | $17.38 | 2025 | Venxxiva |
| Novo Nordisk INC | $15.91 | 2024 | Rivfloza |
| Mission Pharmacal Company | $14.00 | 2023 | Lithostat |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Delagrange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.